特力利汀

{{Drugbox
| drug_name = 特力利汀
Teneligliptin
| IUPAC_name = {(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-pyrrolidinyl}(1,3-thiazolidin-3-yl)methanone
| image = Teneligliptin.svg
| alt =
| caption =

| tradename = 「Tenelia」
| Drugs.com =
| MedlinePlus =
| pregnancy_AU =
| pregnancy_US =
| pregnancy_category=
| legal_AU =
| legal_CA =
| legal_UK =
| legal_US =
| legal_status = 在日本通過審批
| routes_of_administration =

| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =

| CAS_number = 760937-92-6
| CAS_number_Ref =
| ATCvet =
| ATC_prefix =
| ATC_suffix =
| PubChem = 11949652
| DrugBank =
| ChemSpiderID =

| C=22 | H=30 | N=6 | O=1 | S=1
| molecular_weight = 426.58 g/mol
| smiles = CC1=NN(C(=C1)N2CCN(CC2)[C@H]3CC@HC(=O)N4CCSC4)C5=CC=CC=C5
| StdInChI=1S/C22H30N6OS/c1-17-13-21(28(24-17)18-5-3-2-4-6-18)26-9-7-25(8-10-26)19-14-20(23-15-19)22(29)27-11-12-30-16-27/h2-6,13,19-20,23H,7-12,14-16H2,1H3/t19-,20-/m0/s1
| StdInChIKey=WGRQANOPCQRCME-PMACEKPBSA-N
}}

特力利汀（國際非專利藥品名稱：Teneligliptin，商品名爲「Tenelia」），係治療2型糖尿病的藥物。目前，該藥已在日本通過相關審批 It belongs to the class of anti-diabetic drugs known as dipeptidyl peptidase-4 inhibitors or "gliptins".

參考
糖尿病藥物